Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Signed Informed Consent and Authorization document
Metastatic, or locally advanced and unresectable, adenocarcinoma of the colon or rectum
Receiving Avastin as a component of first-line chemotherapy
First-line chemotherapy plus Avastin initiated \<=4 months prior to enrollment in the study
You may not be if
Patients who have contraindications for treatment with Avastin (see the Avastin Package Insert) or who would incur excessive risks with Avastin treatment are ineligible for this study.
Clareo Health | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
